Spinifex Pharmaceuticals Overview
- Year Founded
-
2005
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$312M
Spinifex Pharmaceuticals General Information
Description
Developer of a new class of therapeutic for chronic pain management. The company's lead product clinically reduces pain in patients with postherpetic neuralgia, a debilitating condition that can follow shingles, providing patients with treatment for pain relief.
Contact Information
Website
www.spinifexpharma.comCorporate Office
- Corporate One
- Suite G5, 84 Hotham Street
- Preston, Victoria 3072
- Australia
Corporate Office
- Corporate One
- Suite G5, 84 Hotham Street
- Preston, Victoria 3072
- Australia
Spinifex Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Merger/Acquisition | 24-Jul-2015 | $312M | Completed | Clinical Trials - Phase 2 | ||
| 3. Later Stage VC (Series C) | 11-Apr-2014 | Completed | Clinical Trials - Phase 2 | |||
| 2. Later Stage VC (Series B) | 23-Aug-2011 | $19.3M | $19.3M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | 01-Jun-2005 | Completed | Startup |
Spinifex Pharmaceuticals Comparisons
Industry
Financing
Details
Spinifex Pharmaceuticals Competitors (11)
One of Spinifex Pharmaceuticals’s 11 competitors is Xalud Therapeutics, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Xalud Therapeutics | Venture Capital-Backed | New York, NY | ||||
| Centrexion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| SCILEX Holding | Formerly VC-backed | Palo Alto, CA | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Supernus | Formerly VC-backed | Rockville, MD |
Spinifex Pharmaceuticals Patents
Spinifex Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2015003223-A1 | Heterocyclic compounds and methods of their use | Inactive | 08-Jul-2013 | ||
| AU-2013902513-A0 | Method of treatment or prophylaxis | Inactive | 08-Jul-2013 | ||
| AU-2012900286-A0 | "methods of treatment or prophylaxis" | Inactive | 25-Jan-2012 | ||
| WO-2013110134-A1 | Heterocyclic compounds and methods for their use | Inactive | 25-Jan-2012 | ||
| WO-2013110135-A1 | Heterocyclic compounds and methods for their use | Inactive | 25-Jan-2012 | C07D401/04 |
Spinifex Pharmaceuticals Former Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brandon Capital | Venture Capital | Minority | ||
| Canaan Partners | Venture Capital | Minority | ||
| GBS Venture Partners | Venture Capital | Minority | ||
| Innovation Works | Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority |
Spinifex Pharmaceuticals FAQs
-
When was Spinifex Pharmaceuticals founded?
Spinifex Pharmaceuticals was founded in 2005.
-
Where is Spinifex Pharmaceuticals headquartered?
Spinifex Pharmaceuticals is headquartered in Preston, Australia.
-
What industry is Spinifex Pharmaceuticals in?
Spinifex Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Spinifex Pharmaceuticals a private or public company?
Spinifex Pharmaceuticals is a Private company.
-
What is the current valuation of Spinifex Pharmaceuticals?
The current valuation of Spinifex Pharmaceuticals is .
-
What is Spinifex Pharmaceuticals’s current revenue?
The current revenue for Spinifex Pharmaceuticals is .
-
How much funding has Spinifex Pharmaceuticals raised over time?
Spinifex Pharmaceuticals has raised $70M.
-
Who are Spinifex Pharmaceuticals’s investors?
Brandon Capital, Canaan Partners, GBS Venture Partners, Innovation Works, and Novo Holdings are 5 of 7 investors who have invested in Spinifex Pharmaceuticals.
-
Who are Spinifex Pharmaceuticals’s competitors?
Xalud Therapeutics, Centrexion Therapeutics, SCILEX Holding, Rein Therapeutics, and Supernus are some of the 11 competitors of Spinifex Pharmaceuticals.
-
When was Spinifex Pharmaceuticals acquired?
Spinifex Pharmaceuticals was acquired on 24-Jul-2015.
-
Who acquired Spinifex Pharmaceuticals?
Spinifex Pharmaceuticals was acquired by Novartis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process